5 Jul 2016 | Medication Safety
The Health Quality & Safety Commission welcomes sector feedback on a draft alteplase/tenectaplase medication safety alert.
The alert has been developed with the National Stroke Network after a third serious adverse event was reported to the Commission.
The draft has been sent to DHB chief medical officers, directors of nursing, chief pharmacists and quality and risk managers for distribution to relevant clinicians. Relevant colleges and societies have also received the draft for distribution and feedback. The closing date for feedback is 5pm, 15 July 2016.